ClinicalTrials.gg
Not yet recruitingNCT07886411MERITEST TSUpdated Oct 21, 2026

Three-dimensional Biomechanics of the Lower Limbs in Healthy Volunteers: Establishment of a Reference Database Using the MERItest® System

An interventional study of MERITest in Healthy Adult Participants and Anterior Cruciate Ligament (ACL), sponsored by Clinique du Sport, Bordeaux Mérignac. Not yet recruiting at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Clinique du Sport, Bordeaux Mérignac · Not applicable, Interventional, and Supportive care

Updated Oct 21, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Anterior cruciate ligament (ACL) reconstruction is frequently associated with persistent biomechanical impairments despite clinically satisfactory recovery. The MERItest® is a standardized biomechanical assessment battery designed to evaluate movement strategies, muscle strength, and neuromuscular control during functional tasks. However, the clinical interpretation of these assessments is currently limited by the lack of normative data collected using a standardized protocol.

This single-center, prospective interventional trial involving minimal risk, aims to establish a biomechanical reference database of healthy volunteers based on measurements obtained during the MERItest® assessment.

The development of this normative database will enhance the interpretation of biomechanical outcomes in patients following ACL reconstruction by enabling direct comparison with a healthy reference population assessed under identical conditions.

02

Conditions studied

  • Healthy Adult Participants
  • Anterior Cruciate Ligament (ACL)

Keywords

  • MERITest
  • Biomechanical reference
03

In context

Lead sponsor

Clinique du Sport, Bordeaux Mérignac is the lead sponsor of 11 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Asymptomatic with respect to the lower limbs at the time of inclusion
  • Regular participation in sports activities compatible with completion of the MERItest® (at least twice per week)
  • Ability to perform all tasks included in the study protocol, including running, jumping, single-leg landings, hop tests, and strength assessments

Exclusion criteria

Exclusion Criteria:

  • History of lower-limb surgery
  • History of anterior cruciate ligament (ACL) rupture or other major knee ligament injury
  • History of a lower-limb fracture resulting in functional impairment
  • History of symptomatic meniscal, cartilage, or tendon pathology affecting the lower limb
  • Current pain, functional limitation, or injury involving the spine, pelvis, or lower limbs
  • Any painful or traumatic event within the previous month that could affect test performance
  • History or presence of a neurological or vestibular disorder likely to impair motor control
  • Current use of medications that may affect physical or muscular performance (e.g., anti-inflammatory drugs, , muscle relaxants)
  • Medical to performing the exercises included in the study protocol
  • Inability to complete the entire MERItest® under standardized testing conditions
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Healthy Volonteers

    Healthy volunteers will undergo the MERItest® during a single visit lasting approximately one hour. The assessment will be conducted by an experienced movement biomechanics specialist. Reflective markers (Qualisys Sports Marker Set - Functional Assessment) will then be placed on both lower limbs at the hip, knee, and ankle levels. These markers enable the collection of biomechanical data in the sagittal, frontal, and transverse planes, as well as side-to-side comparisons. Biomechanical assessment is performed using a combination of reflective markers, three-dimensional optoelectronic motion-capture cameras, and force and pressure platforms.

    Other: MERITest

Interventions

  • OtherMERITest

    Healthy volunteers will undergo the MERItest® during a single visit lasting approximately one hour. The assessment will be conducted by an experienced movement biomechanics specialist. Starting with a standardized dynamic warm-up, including walking, walking lunges, and half-squats, to prepare participants for the functional tasks and reduce injury risk. Reflective markers (Qualisys Sports Marker Set - Functional Assessment) will then be placed on both lower limbs at the hip, knee, and ankle levels. These markers enable the collection of biomechanical data in the sagittal, frontal, and transverse planes, as well as side-to-side comparisons. Biomechanical assessment is performed using a combination of reflective markers, three-dimensional optoelectronic motion-capture cameras, and force and pressure platforms.

    Also known as: Biomedical evaluation

06

What researchers measure

Primary outcomes

  1. Kinematic Parameters Assessed During the MERItest®

    During running, Countermovement Jump (CMJ), bipodal drop jump, unipodal drop jump and Hop tests: Knee Flexion Excursion (°) Peak Knee Flexion (°) Foot Eversion Excursion (°) Trunk Lateral Lean (°) Contralateral Pelvic Drop (°) Hip Adduction Excursion (°) Knee Abduction Excursion (°)

    Time frame: 1 day

Secondary outcomes

  1. Reaction Forces During Functional Tasks Assessed With the MERItest®

    Vertical and horizontal ground reaction force parameters measured during running, countermovement jump, bipodal drop jump, unipodal drop jump and hop tests using force platforms. Unit of measure: * Vertical Ground Reaction Force (N/BW) * Horizontal Ground Reaction Force (N/BW)

    Time frame: 1 day

  2. Temporal Parameters Assessed During the MERItest®

    Ground contact time (s) and flight time (s) measured during running, countermovement jump (CMJ), bipodal drop jump, unipodal drop jump and hop tests performed during the MERItest®.

    Time frame: 1 day

  3. Physiological asymmetries between the lower limbs

    Physiological asymmetries between the lower limbs (Asymmetry Index, %)

    Time frame: 1 day

  4. Moment Assessed During the MERItest®

    During running, Countermovement Jump (CMJ), bipodal drop jump, unipodal drop jump and Hop tests: Knee Extension Moment (Nm/kg) Knee Abduction Moment (Nm/kg)

    Time frame: 1 day

  5. Impulse Assessed During the MERItest®

    Eccentric impulse (N·s/BW) and concentric impulse (N·s/BW) measured during running, countermovement jump (CMJ), bipodal drop jump, unipodal drop jump and hop tests performed during the MERItest®.

    Time frame: 1 day

  6. Power Measured During the MERItest®

    During running, Countermovement Jump (CMJ), bipodal drop jump, unipodal drop jump and Hop tests: Hip Power (W/kg) Knee Power (W/kg) Ankle Power (W/kg) Knee Extension Power (W/kg)

    Time frame: 1 day

  7. Rate of Force Development Assessed During the MERItest®

    Rate of Force Development (RFD) (N·s-¹) measured during running, countermovement jump (CMJ), bipodal drop jump, unipodal drop jump and hop tests performed during the MERItest®.

    Time frame: 1 day

  8. Jump Performance Parameters Assessed During the MERItest®

    Jump height (m) and hop distance (m) measured during countermovement jump (CMJ), bipodal drop jump, unipodal drop jump and hop tests performed during the MERItest®.

    Time frame: 1 day

  9. Reactive Strength Index Assessed During the MERItest®

    Reactive Strength Index (RSI) (m/s) measured during bipodal drop jump and unipodal drop jump tests performed during the MERItest®.

    Time frame: 1 day

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07886411
Lead sponsor
Clinique du Sport, Bordeaux Mérignac
Responsible party
Sponsor
First posted
Oct 21, 2026
Start date
Oct 15, 2026 (estimated)
Primary completion
Oct 15, 2027 (estimated)
Completion
Oct 15, 2027 (estimated)
Last update
Oct 21, 2026

Study contacts

Marion Mandon, PhD
Contact
DRC@vivalto-sante.com
+33 6 78 27 76 72
Emma Escoffier, Master
Contact
eescoffier@vivalto-santé.com
+ 33 6 88 92 33 17
Nicolas Bouguennec, MD
principal investigator · Clinique du sport

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion